Log In
Print
BCIQ
Print
Print this Print this
 

Altrazeal

  Manage Alerts
Collapse Summary General Information
Company Uluru Inc.
DescriptionAntimicrobial dressing incorporating the company's Nanoflex nanoparticle aggregate technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationWounds
Indication DetailsTreat wounds at skin graft donor sites
Regulatory Designation
Partner Jiangxi Aiqilin Pharmaceuticals Group; Melmed Holdings AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today